SE8402551D0 - Cinnamoylmoranolin-derivat - Google Patents

Cinnamoylmoranolin-derivat

Info

Publication number
SE8402551D0
SE8402551D0 SE8402551A SE8402551A SE8402551D0 SE 8402551 D0 SE8402551 D0 SE 8402551D0 SE 8402551 A SE8402551 A SE 8402551A SE 8402551 A SE8402551 A SE 8402551A SE 8402551 D0 SE8402551 D0 SE 8402551D0
Authority
SE
Sweden
Prior art keywords
cinnamoylmoranolin
derivatives
same
aralkylmoranoline
aralkenylmoranoline
Prior art date
Application number
SE8402551A
Other languages
English (en)
Other versions
SE451017B (sv
SE8402551L (sv
Inventor
S Matsumura
H Enomoto
Y Aoyagi
Y Yoshikuni
K Kura
M Yagi
I Shirahase
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP53053603A external-priority patent/JPS5943947B2/ja
Priority claimed from JP8260678A external-priority patent/JPS5943948B2/ja
Priority claimed from JP12066178A external-priority patent/JPS5943949B2/ja
Priority claimed from JP571479A external-priority patent/JPS6026387B2/ja
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of SE8402551D0 publication Critical patent/SE8402551D0/sv
Publication of SE8402551L publication Critical patent/SE8402551L/sv
Publication of SE451017B publication Critical patent/SE451017B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8402551A 1978-05-03 1984-05-11 Cinnamylmoranolin-derivat SE451017B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP53053603A JPS5943947B2 (ja) 1978-05-03 1978-05-03 Ｎ−置換モラノリン誘導体
JP8260678A JPS5943948B2 (ja) 1978-07-06 1978-07-06 置換モラノリン誘導体
JP12066178A JPS5943949B2 (ja) 1978-09-29 1978-09-29 モラノリンのｎ−置換誘導体
JP571479A JPS6026387B2 (ja) 1979-01-20 1979-01-20 シンナミルモラノリン誘導体

Publications (3)

Publication Number Publication Date
SE8402551D0 true SE8402551D0 (sv) 1984-05-11
SE8402551L SE8402551L (sv) 1984-05-11
SE451017B SE451017B (sv) 1987-08-24

Family

ID=27454348

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7903817A SE436874B (sv) 1978-05-03 1979-05-02 N-substituerade moranolinderivat
SE8402551A SE451017B (sv) 1978-05-03 1984-05-11 Cinnamylmoranolin-derivat
SE8402549A SE451015B (sv) 1978-05-03 1984-05-11 Substituerade moranolinderivat
SE8402550A SE451016B (sv) 1978-05-03 1984-05-11 N-substituerade derivat av moranolin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7903817A SE436874B (sv) 1978-05-03 1979-05-02 N-substituerade moranolinderivat

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8402549A SE451015B (sv) 1978-05-03 1984-05-11 Substituerade moranolinderivat
SE8402550A SE451016B (sv) 1978-05-03 1984-05-11 N-substituerade derivat av moranolin

Country Status (9)

Country Link
US (1) US4533668A (sv)
CH (1) CH642629A5 (sv)
DE (1) DE2915037C3 (sv)
DK (1) DK151623C (sv)
FR (1) FR2424910A1 (sv)
GB (1) GB2020278B (sv)
IT (1) IT1116820B (sv)
NL (1) NL175820C (sv)
SE (4) SE436874B (sv)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2925943A1 (de) * 1979-06-27 1981-01-29 Bayer Ag 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2942365A1 (de) * 1979-10-19 1981-05-14 Bayer Ag, 5090 Leverkusen 2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
JP2504000B2 (ja) * 1986-09-02 1996-06-05 日本新薬株式会社 グルコシルモラノリン誘導体
JPS6461459A (en) * 1987-08-28 1989-03-08 Nippon Shinyaku Co Ltd Moranoline derivative
GB8827701D0 (en) * 1987-12-09 1988-12-29 Nippon Shinyaku Co Ltd Thrombolytic &c compositions
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
US4985445A (en) * 1988-02-12 1991-01-15 Meiji Seika Kaisha, Ltd. Cancer cell metastasis inhibitors and novel compounds
EP0350012A3 (en) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antiviral composition
ATE142201T1 (de) * 1992-04-01 1996-09-15 Searle & Co 2- und 3-amino und azidoderivate von 1,5- iminozuckern als antivirale arzneimittel
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5342951A (en) * 1992-04-01 1994-08-30 G.D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5798366A (en) * 1993-05-13 1998-08-25 Monsanto Company Method for treatment of CNS-involved lysosomal storage diseases
US6291657B1 (en) * 1993-05-13 2001-09-18 Monsanto Company Deoxygalactonojirimycin derivatives
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
JP2001522833A (ja) * 1997-11-10 2001-11-20 ジー・ディー・サール・アンド・カンパニー 多剤耐性を治療するためのアルキル化イミノ糖類の使用
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
ATE331515T1 (de) 1998-02-12 2006-07-15 Searle Llc Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen
US6515028B1 (en) 1999-02-12 2003-02-04 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
DE60039729D1 (de) 1999-02-12 2008-09-11 United Therapeutics Corp N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
AU2001236938A1 (en) * 2000-02-14 2001-08-27 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
US8003617B2 (en) * 2004-11-10 2011-08-23 Genzyme Corporation Methods of treating diabetes mellitus
AT502145B1 (de) * 2005-03-24 2012-01-15 Univ Graz Tech Glycosidase-hemmendes iminoalditol
HUE026057T2 (en) * 2006-05-09 2016-05-30 Genzyme Corp Procedures for the Treatment of Fatty Liver Disease, which comprises inhibition of glycosphingolipid synthesis
US8975280B2 (en) * 2006-05-24 2015-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Deoxynojirimycin and D-arabinitol analogs and methods of using
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
WO2008150486A2 (en) 2007-05-31 2008-12-11 Genzyme Corporation 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
EP2550965B1 (en) * 2007-10-05 2019-01-16 Genzyme Corporation Ceramide derivatives for treating polycystic kidney disease
WO2010014554A1 (en) 2008-07-28 2010-02-04 Genzyme Corporation Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
EP2349255B1 (en) * 2008-10-03 2016-03-30 Genzyme Corporation 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
BR112018072298A2 (pt) 2016-05-02 2019-02-12 Florida State University Research Foundation, Inc. tratamento de infecções pelo vírus da zika usando inibidores da alfa-glicosidase
US11369592B2 (en) 2020-02-21 2022-06-28 Florida State University Research Foundation, Inc. Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
JP2023525250A (ja) * 2020-05-07 2023-06-15 アレクトス セラピューティックス インコーポレイテッド 非リソソームグルコシルセラミダーゼ阻害剤及びその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5282710A (en) * 1975-12-29 1977-07-11 Nippon Shinyaku Co Ltd Extraction of effective drug component from mulberry
DE2735316C3 (de) * 1977-08-05 1981-01-29 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von nadeiförmigen, ferrimagnetischen Eisenoxiden

Also Published As

Publication number Publication date
SE451015B (sv) 1987-08-24
DK151623B (da) 1987-12-21
CH642629A5 (de) 1984-04-30
NL175820B (nl) 1984-08-01
NL7903421A (nl) 1979-11-06
SE8402549D0 (sv) 1984-05-11
SE451017B (sv) 1987-08-24
SE8402551L (sv) 1984-05-11
IT1116820B (it) 1986-02-10
SE8402549L (sv) 1984-05-11
DK178379A (da) 1979-11-04
US4533668A (en) 1985-08-06
SE436874B (sv) 1985-01-28
DE2915037C3 (de) 1981-11-05
GB2020278A (en) 1979-11-14
FR2424910A1 (fr) 1979-11-30
GB2020278B (en) 1983-02-23
DK151623C (da) 1988-07-18
FR2424910B1 (sv) 1981-12-11
IT7948904A0 (it) 1979-05-02
SE8402550D0 (sv) 1984-05-11
NL175820C (nl) 1985-01-02
SE451016B (sv) 1987-08-24
SE8402550L (sv) 1984-05-11
DE2915037B2 (de) 1981-01-29
SE7903817L (sv) 1979-11-04
DE2915037A1 (de) 1979-11-08

Similar Documents

Publication Publication Date Title
SE8402551D0 (sv) Cinnamoylmoranolin-derivat
IT8122859A0 (it) Derivati dell'acido 2-idrossi-5-fenilazobenzoico, composizioni farmaceutiche che licontengono e procedimento per laloro preparazione.
NL191150B (nl) N-(L-leucyl) doxorubicine en zuur-additiezouten daarvan, werkwijze ter bereiding en farmaceutische preparaat.
JPS5412372A (en) Thiazolidine derivative and its preparation
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ATE921T1 (de) Saeureadditionssalze von 2-beta, 16-beta-bis-piperidino-an drostan-16-beta-monoquaternaeren ammoniumderivaten und diese enthaltende pharmazeutische zusammensetzungen.
IT7927748A0 (it) Derivati dell'acido 6,6'-diapopsi psicarotenedioico e relativi procedimenti di preparazione.
IT7829910A0 (it) Derivati dell'acido fosfonoso, procedimenti per la loro preparazione e loro impiego per combattere microorganismi.
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
IT7829133A0 (it) Derivati del6-ossigenato-3,20-diossopregnano, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
FI803202L (fi) Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel
SE8700555L (sv) Purinderivat, deras framstellning och lekemedel innehallande dessa
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
IT1228130B (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
BE792803A (fr) Derives d'acide 8,12-diisoprostanoique optiquement actifs, leurpreparation et compositions en contenant
ES472528A1 (es) Procedimiento para la preparacion de derivados de benzosul- fonamida
AT342761B (de) Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung
FR2496658B1 (fr) Derives de l'acide nicotinique, leur preparation et medicament contenant ces substances
SE7902817L (sv) Substituerade /4h/ 1,3-bensodioxin-2-karboxylsyraderivat, framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa
IT7822047A0 (it) Derivati d'acidi furoil-o tenoil-naftilossialchil-carbossilici, loro preparazione e loro impiego come medicamenti.
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
JPS53148526A (en) Aseptic and mildewcidal agent for food
ES455692A1 (es) Procedimiento para la produccion de derivados de alquilen- dioxipiperacina.
FR2470111B1 (fr) Derives de la decaprenylamine, leurs sels acides d'addition et composition pharmaceutique utilisant ces produits

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8402551-9

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8402551-9

Format of ref document f/p: F